Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target the mechanism that makes these tumors so deadly.
Articles on Oncogenes
Displaying all articles
Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target the mechanism that makes these tumors so deadly.
Your body has trillions of cells. But a gene mutation in just one of them could prove fatal.
Tumors contain thousands of genetic changes, but only a few are actually cancer-causing. A quicker way to identify these driver mutations could lead to more targeted cancer treatments.
Every cancer is different. Grouping cancer mutations by their structure and function could help make treatments more personalized.
Top contributors
-
Professor of Medical Oncology, University of Colorado Anschutz
-
Assistant Professor of Thoracic & Head and Neck Oncology, The University of Texas MD Anderson Cancer Center
-
Assistant Professor of Computer Science, University of Colorado Boulder
-
Senior Research Officer, Blood Cells and Blood Cancer, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Senior Research Officer, Blood Cells and Blood Cancer Division, WEHI (Walter and Eliza Hall Institute of Medical Research)